References
- Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 2000; 32: 113–28
- Nicolas JM, Fernandez-Sola J, Estruch R, Pare JC, Sacanella E, Urbano-Marquez A, Rubin E. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 2002; 136: 192–200
- Purohit V, Russo D, Salin M, Brown R. Mechanisms of alcoholic pancreatitis: introduction and summary of the symposium. Pancreas 2003; 27: 281–5
- Leevy CB, Leevy CM. Alcoholic liver disease. Compr Ther 1994; 20: 6–9
- Diehl AM. Liver disease in alcohol abusers: clinical perspective. Alcohol 2002; 27: 7–11
- Sillanauke P. Laboratory markers of alcohol abuse. Alcohol Alcoholism 1996; 31: 613–16
- Himmerich H, Anghelescu I, Klawe C, Szegedi A. Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients. Alcohol Alcoholism 2001; 36: 26–8
- Mowe M, Bohmer T. Increased levels of alcohol markers (gamma GT, MCV, ASAT, ALAT) in older patients are not related to high alcohol intake. J Am Geriatr Soc 1996; 44: 1136–7
- Wetterling T, Kanitz RD, Rumpf HJ, Hapke U, Fischer D. Comparison of cage and mast with the alcohol markers CDT, gamma-GT, ALAT, ASAT and MCV. Alcohol Alcoholism 1998; 33: 424–30
- Borini P, Guimaraes RC. Liver synthesis function in chronic asymptomatic or oligosymptomatic alcoholics: Correlation with other liver tests. Rev Hosp Clin Fac Med Sao Paolo 1999; 54: 97–102
- Poikolainen K, Podkletnova I, Alho H. Accuracy of quantity-frequency and graduated frequency questionnaires measuring alcohol intake: Comparison with daily diary and commonly used laboratory markers. Alcohol Alcohol 2002; 37: 573–6
- Swendsen JD, Merikangas KR, Canino GJ, Kessler RC, Rubio-Stipec M, Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry 1998; 39: 176–84
- Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: Results of a national survey. Drug Alcohol Depend 1995; 39: 197–206
- Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985; 42: 1050–5
- Helzer E, Przybeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988; 49: 219–24
- Kessler RC, Crum RM, Warner LA. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–21
- Regier DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc 1990; 264: 2511–18
- Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. Alcohol detoxification and social anxiety symptoms: A preliminary study of the impact of mirtazapine administration. J Affect Disord 2003; 76: 279–84
- Liappas J, Paparrigopoulos T, Malitas P, Tzavellas E, Christodoulou G. Mirtazapine improves alcohol detoxification. J Psychopharmacol 2004; 18: 77–82
- Brown WE, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol 1988; 49: 412–17
- Schuckit MA, Tipp JE, Bergman M. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997; 154: 948–57
- Brown SA, Irwin M, Schuckit MA. Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 1991; 52: 55–61
- Brown SA, Inaba RK, Gillin CJ, Schuckit MA, Stewart MA, Irwin MR. Alcoholism and affective disorder: Clinical course of depressive symptoms. Am J Psychiatry 1995; 152: 45–52
- Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend 2002; 68: 215–20
- Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990; 147: 685–95
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
- Hamilton M. The assessment of anxiety rates by rating. Br J Med Psychol 1959; 32: 50–5
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
- Guy W. Clinical global impression. In: EDCEU assessment manual for Psychopharmacology, rev. ed. Rockville, MD: US Department of Health, Education and Welfare; 1976. p 217–22.
- Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment Scale. A procedure for measuring over severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766–71
- Hughes PH, Venulet J, Khant U. Core data for epidemiological studies on nonmedical drug use (Offset Publication 56). World Health Organization, Geneva 1980
- Daeppen JB, Schoenfeld-Smith K, Smith TL, Schukitt MA. Characteristics of alcohol dependent subjects with very elevated levels of gamma-glutamyltransferase (GGT). J Stud Alcohol 1999; 60: 589–94
- Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002; 26: 1215–22
- Gomberg ES. Recent developments in alcoholism: Gender issues. Rec DevAlcohol 1993; 11: 95–107
- Salaspuro M. Use of enzymes for the diagnosis of alcohol-related organ damage. Enzyme 1987; 37: 87–107
- Weiss KJ, Rosenberge DJ. Prevalence of anxiety disorder among alcoholics. J. Clin. Psychiatry 2003; 18: 128–39
- Ham LS, Hope DA. Alcohol and anxiety: Subtle and obvious attributes of abuse in adults with social anxiety disorder and panic disorder. Depress Anxiety 2003; 18: 128–39
- Nurnberger JI, Jr, Foroud T, Flury L, Meyer ET, Wiegand R. Is there a genetic relationship between alcoholism and depression?. Alcohol Res Health 2002; 26: 233–40
- Bierut LJ, Saccone NL, Rice JP, Goate A, Foroud T, Edenberg H, et al. Defining alcohol-related phenotypes in human. The Collaborative Study of Genetics of Alcoholism. Alcohol Res Health 2002; 26: 208–13
- Sullivan JT, Skykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 1989; 84: 1353–7
- World Health Organization. Composite International Diagnostic Interview-CIDI, Core Version 1.0. Division of Mental Health, World Health Organization, Geneva 1990
- Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997; 154(7)948–57
- Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, Wiedemann K. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 2005; 11(2)83–91
- Walter H, Gutierrez K, Ramskogler K, Hertling I, Dvorak A, Lesch OM. Gender-specific differences in alcoholism: Implications for treatment. Arch Women Ment Health 2003; 6(4)253–8
- Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. J Am Med Assoc 2004; 291(15)1887–96
- Lesch OM, Walter H, Antal J, Heggli DE, Kovacz A, Leitner A, et al. Carbohydrate-deficient transferrin as a marker of alcohol intake: a study with healthy subjects. Alcohol Alcohol 1996; 31(3)265–71
- Lesch OM, Walter H, Freitag H, Heggli DE, Leitner A, Mader R, et al. Carbohydrate-deficient transferrin as a screening marker for drinking in a general hospital population. Alcohol Alcohol 1996; 31(3)249–56